Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.
2.

Getting the most out of PubChem for virtual screening.

Kim S.

Expert Opin Drug Discov. 2016 Sep;11(9):843-55. doi: 10.1080/17460441.2016.1216967. Epub 2016 Aug 5. Review.

3.

Decision tree models for data mining in hit discovery.

Hammann F, Drewe J.

Expert Opin Drug Discov. 2012 Apr;7(4):341-52. doi: 10.1517/17460441.2012.668182. Epub 2012 Feb 29. Review.

PMID:
22458505
4.

Data mining as a tool for research and knowledge development in nursing.

Berger AM, Berger CR.

Comput Inform Nurs. 2004 May-Jun;22(3):123-31. Review.

PMID:
15520581
5.

Big data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicants.

Zhu H, Zhang J, Kim MT, Boison A, Sedykh A, Moran K.

Chem Res Toxicol. 2014 Oct 20;27(10):1643-51. doi: 10.1021/tx500145h. Epub 2014 Sep 16. Review.

6.

Contributions of computational chemistry and biophysical techniques to fragment-based drug discovery.

Gozalbes R, Carbajo RJ, Pineda-Lucena A.

Curr Med Chem. 2010;17(17):1769-94. Review.

PMID:
20345344
7.

Integrating virtual screening and combinatorial chemistry for accelerated drug discovery.

López-Vallejo F, Caulfield T, Martínez-Mayorga K, Giulianotti MA, Nefzi A, Houghten RA, Medina-Franco JL.

Comb Chem High Throughput Screen. 2011 Jul;14(6):475-87. Review.

PMID:
21521151
8.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
9.

Charting, navigating, and populating natural product chemical space for drug discovery.

Lachance H, Wetzel S, Kumar K, Waldmann H.

J Med Chem. 2012 Jul 12;55(13):5989-6001. doi: 10.1021/jm300288g. Epub 2012 May 11. Review.

PMID:
22537178
10.

Cheminformatics approaches to analyze diversity in compound screening libraries.

Akella LB, DeCaprio D.

Curr Opin Chem Biol. 2010 Jun;14(3):325-30. doi: 10.1016/j.cbpa.2010.03.017. Epub 2010 Apr 22. Review.

PMID:
20457001
11.

Novel trends in high-throughput screening.

Mayr LM, Bojanic D.

Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Review.

PMID:
19775937
12.

Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Roy A, McDonald PR, Sittampalam S, Chaguturu R.

Curr Pharm Biotechnol. 2010 Nov;11(7):764-78. Review.

13.

Probe Reports from the NIH Molecular Libraries Program [Internet].

Bethesda (MD): National Center for Biotechnology Information (US); 2010-.

14.

Cell-based assays for high-throughput screening.

An WF, Tolliday N.

Mol Biotechnol. 2010 Jun;45(2):180-6. doi: 10.1007/s12033-010-9251-z. Review.

PMID:
20151227
15.

Composition and applications of focus libraries to phenotypic assays.

Wassermann AM, Camargo LM, Auld DS.

Front Pharmacol. 2014 Jul 24;5:164. doi: 10.3389/fphar.2014.00164. eCollection 2014. Review.

16.

Assay Interference by Chemical Reactivity.

Dahlin JL, Baell J, Walters MA.

In: Sittampalam GS, Coussens NP, Brimacombe K, Grossman A, Arkin M, Auld D, Austin C, Baell J, Bejcek B, Chung TDY, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Hass JV, Inglese J, Iversen PW, Kahl SD, Kales SC, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Trask OJ Jr., Weidner JR, Xia M, Xu X, editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
2015 Sep 18.

17.

A comprehensive company database analysis of biological assay variability.

Kramer C, Dahl G, Tyrchan C, Ulander J.

Drug Discov Today. 2016 Aug;21(8):1213-21. doi: 10.1016/j.drudis.2016.03.015. Epub 2016 Apr 7. Review.

PMID:
27063506

Supplemental Content

Support Center